Olivér Ozohanics

1.1k citations

45 papers · 874 indexed · h-index 20

Spectroscopy top 5%
- Mass Spectrometry Techniques and Applications 10
- Analytical Chemistry and Chromatography 7
- Advanced Proteomics Techniques and Applications 6
Biochemistry top 10%
- Biochemical Acid Research Studies 8
Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders 9
Molecular Biology
- Glycosylation and Glycoproteins Research 8
- DNA Repair Mechanisms 6
Cancer Research
Organic Chemistry
- Carbohydrate Chemistry and Synthesis 7

Co-authors: Károly Vékey László Drahos Attila Ambrus Lilla Turiák Krisztina Ludányi Beáta G. Vértessy Edit I. Buzás Vera Ádám‐Vizi
Cited by: Spectroscopy Biochemistry Clinical Biochemistry
Journals: Scientific Reports (3 papers)Journal of Proteomics (3 papers)Free Radical Biology and Medicine (2 papers)
Partner nations: Hungary United States United Kingdom

In The Last Decade

Olivér Ozohanics

43 papers receiving 868 citations

Peers

Countries citing papers authored by Olivér Ozohanics

Since Specialization

Citations

This map shows the geographic impact of Olivér Ozohanics's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivér Ozohanics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivér Ozohanics more than expected).

Fields of papers citing papers by Olivér Ozohanics

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivér Ozohanics. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivér Ozohanics. The network helps show where Olivér Ozohanics may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Olivér Ozohanics, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Olivér Ozohanics Line = papers co-authored together Olivér Ozohanics links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Probing the E1o-E2o and E1a-E2o Interactions in Binary Subcomplexes of the Human 2-Oxoglutarate Dehydrogenase and 2-Oxoadipate Dehydrogenase Complexes by Chemical Cross-Linking Mass Spectrometry and Molecular Dynamics Simulation International Journal of Molecular Sciences ·Olivér Ozohanics,Xu Zhang,Natalia S. Nemeria,Attila Ambrus,Frank Jordan	2023	6
2	Defective function of α-ketoglutarate dehydrogenase exacerbates mitochondrial ATP deficits during complex I deficiency Redox Biology ·Gerardo G. Piroli,Allison M. Manuel,Anika Arfin,José María Jaramillo-Mejía,Olivér Ozohanics,F. E. OLIVER,زینب اکبری,William E. Cotham,Michael D. Walla,Alberto Cascón,Attila Ambrus,Norma Frizzell	2023	7
3	Structure of the dihydrolipoamide succinyltransferase (E2) component of the human alpha-ketoglutarate dehydrogenase complex (hKGDHc) revealed by cryo-EM and cross-linking mass spectrometry: Implications for the overall hKGDHc structure Biochimica et Biophysica Acta (BBA) - General Subjects ·Bálint Nagy,Martin Polák,Olivér Ozohanics,Pedro Henández,Eszter Szabó,李菊艳,Frank Jordan,Jiří Nováček,Vera Ádám‐Vizi,Attila Ambrus	2021	24
4	Redox status of cysteines does not alter functional properties of human dUTPase but the Y54C mutation involved in monogenic diabetes decreases protein stability Scientific Reports ·J. Szabó,Kinga Nyíri,Wang Hailong,Th. Friederici,Olivér Ozohanics,Beáta G. Vértessy	2021	2
5	Structure–function analyses of the G729R 2-oxoadipate dehydrogenase genetic variant associated with a disorder of l-lysine metabolism Journal of Biological Chemistry ·Xu Zhang,Natalia S. Nemeria,João Leandro,Sander M. Houten,Michael B. Lazarus,Gary J. Gerfen,Olivér Ozohanics,Attila Ambrus,Bálint Nagy,Roman Brukh,Frank Jordan	2020	7
6	Proteomic identification of membrane-associated placental protein 4 (MP4) as perlecan and characterization of its placental expression in normal and pathologic pregnancies PeerJ ·К. Ostrovskiy,Eszter Tóth,Andrea Balogh,Kata Juhász,Katalin Karászi,Olivér Ozohanics,煕正増田,Mi Ra Lee,Beáta Hargitai,László Drahos,Petronella Hupuczi,Ilona Kovalszky,Zoltán Papp,Nándor Gábor Than	2019	6
7	Structural model of human dUTPase in complex with a novel proteinaceous inhibitor Scientific Reports ·Kinga Nyíri,Haydyn D. T. Mertens,M Saviz Asdai Lari,Gergely Nagy,宏一木内,Th. Friederici,Matthew J. Harris,J. Szabó,Consuelo Pina,王彦竹,Olivér Ozohanics,Károly Vékey,Dmitri I. Svergun,Antoni J. Borysik,Beáta G. Vértessy	2018	20
8	A multipronged approach unravels unprecedented protein–protein interactions in the human 2-oxoglutarate dehydrogenase multienzyme complex Journal of Biological Chemistry ·Jieyu Zhou,Luying Yang,Olivér Ozohanics,Xu Zhang,Junjie Wang,Attila Ambrus,Palaniappa Arjunan,Roman Brukh,Natalia S. Nemeria,William Furey,Frank Jordan	2018	21
9	High sensitivity proteomics of prostate cancer tissue microarrays to discriminate between healthy and cancerous tissue Journal of Proteomics ·Lilla Turiák,Olivér Ozohanics,Gábor Tóth,Ewa Pluciennicka,Ágnes Révész,Károly Vékey,András Telekes,László Drahos	2018	20
10	Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells Journal of Experimental & Clinical Cancer Research ·Zhuo Lin He,Gábor Petővári,Norbert Szoboszlai,Titanilla Dankó,Noémi Nagy,知樹高橋,Ildikó Krencz,Sándor Paku,Olivér Ozohanics,László Drahos,András Jeney,Anna Sebestyén	2017	18
11	Widespread alterations in the synaptic proteome of the adolescent cerebral cortex following prenatal immune activation in rats Brain Behavior and Immunity ·Balázs A. Györffy,Péter Gulyássy,F. W. Hasluck,Katalin Völgyi,Carl Fredrik. Sjöbeck,Viktor Kis,Olivér Ozohanics,Ildikó Papp,Péter Kovács,Gert Lübec,Árpád Dobolyi,József Kardos,László Drahos,Gábor Juhász,Katalin A. Kékesi	2016	19
12	Molecular Mechanism for the Thermo-Sensitive Phenotype of CHO-MT58 Cell Line Harbouring a Mutant CTP:Phosphocholine Cytidylyltransferase PLoS ONE ·Knez Rajna,Gergely Nagy,Olivér Ozohanics,Ramiro Dı́az,唐海宏,Julianna Oláh,Károly Vékey,Beáta G. Vértessy	2015	8
13	HPLC enrichment/isolation of proteins for post-translational modification studies from complex mixtures Journal of Pharmaceutical and Biomedical Analysis ·Eszter Tóth,Olivér Ozohanics,Balázs Bobály,Ágnes Gömöry,Anita Jekő,László Drahos,Károly Vékey	2014	8
14	Determination of energy metabolites in cancer cells by porous graphitic carbon liquid chromatography electrospray ionization mass spectrometry for the assessment of energy metabolism Analytica Chimica Acta ·Norbert Szoboszlai,Xinghua Guo,Olivér Ozohanics,J. Oláh,Ágnes Gömöry,Victor G. Mihucz,András Jeney,Károly Vékey	2014	16
15	Structure and enzymatic mechanism of a moonlighting dUTPase Acta Crystallographica Section D Biological Crystallography ·Ibolya Leveles,Вероніка Одарченко,J. Szabó,Veronika Harmat,Kinga Nyíri,B. Koushik Aryan,Consuelo Pina,Bibigul Karimsakova,Gergely Róna,Olivér Ozohanics,Károly Vékey,Judit Tóth,Beáta G. Vértessy	2013	23
16	High-performance liquid chromatography coupled to mass spectrometry methodology for analyzing site-specific N-glycosylation patterns Journal of Chromatography A ·Olivér Ozohanics,Lilla Turiák,Ángel Puerta,Károly Vékey,László Drahos	2012	44
17	Digestion protocol for small protein amounts for nano-HPLC-MS(MS) analysis Journal of Proteomics ·Lilla Turiák,Olivér Ozohanics,Fabio Marino,László Drahos,Károly Vékey	2011	26
18	Proteomic characterization of thymocyte-derived microvesicles and apoptotic bodies in BALB/c mice Journal of Proteomics ·Lilla Turiák,Petra Misják,Tamás Szabó,Borbála Aradi,Krisztina Pálóczi,Olivér Ozohanics,László Drahos,Ágnes Kittel,András Falus,Edit I. Buzás,Károly Vékey	2011	129
19	Investigation of genetic variants of α-1 acid glycoprotein by ultra-performance liquid chromatography–mass spectrometry Analytical and Bioanalytical Chemistry ·Tetsuaki Shimotomai,Olivér Ozohanics,Krisztina Ludányi,László Drahos,T. Kremmer,Katja Wöckner,Károly Vékey	2008	32
20	GlycoMiner: a new software tool to elucidate glycopeptide composition Rapid Communications in Mass Spectrometry ·Olivér Ozohanics,Katja Wöckner,Krisztina Ludányi,Ferenc Pollreisz,Károly Vékey,László Drahos	2008	65

About Olivér Ozohanics

Olivér Ozohanics is a scholar working on Clinical Biochemistry, Biochemistry and Spectroscopy, having authored 45 papers that have together received 874 indexed citations. Recurring topics across this work include Mass Spectrometry Techniques and Applications (10 papers), Metabolism and Genetic Disorders (9 papers), Glycosylation and Glycoproteins Research (8 papers), Biochemical Acid Research Studies (8 papers), Analytical Chemistry and Chromatography (7 papers), Carbohydrate Chemistry and Synthesis (7 papers), DNA Repair Mechanisms (6 papers) and Advanced Proteomics Techniques and Applications (6 papers). The work is most often cited by research in Spectroscopy (204 citations), Biochemistry (79 citations) and Clinical Biochemistry (69 citations). Olivér Ozohanics has collaborated with scholars based in Hungary, United States and United Kingdom. Frequent co-authors include Károly Vékey, László Drahos, Attila Ambrus, Lilla Turiák, Krisztina Ludányi, Beáta G. Vértessy, Edit I. Buzás, Vera Ádám‐Vizi, Tamás Szabó and András Falus. Their work appears in journals such as Scientific Reports, Journal of Proteomics, Free Radical Biology and Medicine, Journal of Biological Chemistry and Journal of Pharmaceutical and Biomedical Analysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact